 A project from the American Society of Retina Specialists
 A project from the American Society of Retina SpecialistsSign in to view content
Safety and Efficacy of Switching to Biosimilar Ranibizumab in Eyes Initially Treated With Reference Ranibizumab for nAMD, DME, or RVO
- Video
- Published 2024
Related
Category: AMD-Neovascular